MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
UCLA Medical Center
Santa Mónica, Estados UnidosUCLA Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3
Journal of Clinical Oncology, Vol. 36, Núm. 24, pp. 2465-2472